羟氯喹旁中心性视网膜病变的长期进展
早期病变短期进展有限后趋稳或改善,中度多持续进展,重度全程进展,早期检出或可减少黄斑受累风险。
要点
- 旁中心型羟氯喹视网膜病变的进展与严重程度相关,重度者全程进展。
- 约三分之一早期旁中心型眼短期局限进展后光感受器稳定或改善。
- 旁中心型眼中58.7%出现功能进展,与结构进展对应。
核心结论
- 旁中心型羟氯喹视网膜病变呈严重程度依赖性进展,早期检出可能降低黄斑受累风险。
研究设计与样本
- 采用谱域或扫频源OCT、眼底自发荧光和Humphrey视野检查筛查,分短期(≤2年)与后续期评估进展。
主要发现
- 约三分之一早期旁中心型眼在停药后短期进展有限,随后光感受器稳定或改善。
- 多数中度旁中心型眼持续进展,尤其转为重度阶段时;重度眼全程进展。
- 所有严重度组视网膜变薄速率随时间下降,旁中心型眼58.7%出现功能进展并与结构进展对应。
关键数值与推荐
- OCT进展定义为椭圆体带缺损长度增加、黄斑中心凹至光感受器缺损距离缩短或新发/扩大视网膜色素上皮缺损。
- FAF进展定义为高自发荧光或低自发荧光面积增加。
- 功能进展定义为基于3次以上视野线性回归的平均偏差斜率<0 dB/年且模式标准差斜率>0 dB/年。
临床怎么用
- 对羟氯喹旁中心型视网膜病变按严重度分层随访,重度者需持续监测进展。
- 关注早期检出,以降低旁中心型病变向黄斑中心凹进展的风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the long-term progression of pericentral hydroxychloroquine retinopathy. DESIGN: Multicenter, retrospective cohort study. PARTICIPANTS: Eighty eyes (60 with pericentral pattern) of 41 Korean patients with hydroxychloroquine retinopathy followed up for 2 years or more after drug cessation. METHODS: Patients were screened for hydroxychloroquine retinopathy using spectral-domain or swept-source OCT, fundus autofluorescence (FAF), and Humphrey visual field (VF) tests. Follow-up was divided into short-term (≤2 years) and subsequent periods, and progression was evaluated in each period and severity group. Retinopathy progression on OCT was defined as increased length of the ellipsoid zone defect, decreased distance from the fovea to the photoreceptor defects, or newly developed or enlarged retinal pigment epithelium defects. On FAF, progression was defined as an increase in the area of hyperautofluorescence or hypoautofluorescence. Functional progression was defined as a regression coefficient of less than 0 dB/year for mean deviation and more than 0 dB/year for pattern standard deviation, based on linear regression analysis of 3 or more VF tests. Structural and functional progression rates were calculated using the slopes of retinal thicknesses on the Early Treatment Diabetic Retinopathy Study grid and perimetric parameters over time, respectively. MAIN OUTCOME MEASURES: Structural and functional progression of retinopathy. RESULTS: Approximately one third of eyes with early pericentral retinopathy showed limited progression during the short-term period after drug cessation, but they subsequently showed stable or improved photoreceptors. Most eyes with moderate pericentral retinopathy showed continuous progression, particularly when converted to the severe stage. Severe eyes showed progressive damage throughout the follow-up period. In all severity groups, the rates of retinal thinning decreased over time. In eyes with pericentral retinopathy showing progression, circumferential enlargement of retinal damage was prominent in earlier stages, whereas centripetal enlargement of the ring-shaped lesion was noted in advanced stages. Functional progression, noted in 58.7% of the pericentral eyes, corresponded with structural progression. CONCLUSIONS: Pericentral hydroxychloroquine retinopathy showed severity-dependent progression. Moderate pericentral retinopathy usually progressed, but centripetal progression threatening the fovea was remarkable mostly in severe retinopathy. Our results suggest that early detection of retinopathy may minimize the risk of progression to foveal involvement in pericentral retinopathy.
引用
- Ahn SJ, Seo EJ, Kim KE, et al. Long-Term Progression of Pericentral Hydroxychloroquine Retinopathy. Ophthalmology. 2020. PMID: 33129843. doi:10.1016/j.ophtha.2020.10.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。